Merck Sells Covid Pill for 40 Times What It Costs to Make

A five-day course of molnupiravir, the new medicine being hailed as a “ huge advance ” in the treatment of Covid-19, costs $17.74 to produce, according to a report issued last week by drug pricing experts at the Harvard School of Public Health and King’s College Hospital in London. Merck is charging the U.S. government $712 for the same amount of medicine, or 40 times the price.

Read the source article at theintercept.com
2021-10-02 03:35:00